The guidance informs states how to maintain the temporary increased federal medical assistance percentage while returning to normal Medicaid operations.

Qualified individuals and their families who lose Medicaid or CHIP eligibility once the continuous enrollment requirement ends can apply for marketplace coverage between March 31, 2023, and July 31, 2024.

The Drug Enforcement Administration no longer will require additional registration for prescribers to prescribe buprenorphine.

CMS reports that open enrollment through the health insurance marketplaces for 2023 totals 16.3 million people, a 13 percent increase from 2022.

The association supports HHS' work to align the rule more closely with HIPAA regulations, which will improve care coordination and mitigate discrimination.

A CMS letter to state Medicaid directors clarifies how in lieu of services (ILOS) can be used to mitigate health disparities, limits ILOS expenditures, and adopts documentation and review requirements.

The association supports CMS' work to simplify enrollment and asks the agency to ensure equitable access to beneficiaries’ preferred health care providers.

After the omnibus bill decoupled Medicaid redeterminations from the end of the COVID-19 public health emergency, CMS updates key redetermination dates.

Medicaid and CHIP coverage of interprofessional consultation is permissible as long as the consultation is for the beneficiary's direct benefit.

The report summarizes responses to a 2022 request for information, which focus on eligibility and enrollment, access to hospital services, and payment.

The proposed rule updates essential community provider requirements for qualified health plans and adds a special enrollment period for those disenrolled from Medicaid or CHIP.

A proposed rule will make permanent a temporary policy to allow providers to initiate buprenorphine prescriptions for new patients through telehealth.

The dashboard tracks nonfatal opioid overdoses by state and county and will help service providers target substance use disorder interventions and treatment.

The agency will not enforce a surprise billing requirement that requires good faith estimates to include cost estimates from co-providers and co-facilities.

The proposed rule aims to align Part 2 more closely with HIPAA, improve care coordination, and increase anti-discrimination protections for patients with substance use disorder.

The memo reviews regulatory obligations to care for patients in a safe environment, including the need to identify patients at risk for intentional harm to themselves or others.

The association urges CMS to educate and provide funding for essential hospital staff to conduct Medicaid and CHIP eligibility and enrollment activities.

Financial, educational, and workplace challenges pose obstacles to recruiting and retaining a diverse behavioral health workforce.

Currently, 26 states have extended Medicaid and Children's Health Insurance Program coverage from 60 days to 12 months postpartum.

The roadmap implements the three pillars of the President's March 2022 Strategy to Address our National Mental Health Crisis.

HHS seeks input on the No Surprises Act's advanced explanation of benefits and good faith estimate requirements for insured individuals; comments are due Nov. 15.

An Aug. 31 CMS proposed rule aims to streamline Medicaid and CHIP enrollment and ensure continuous coverage throughout the renewal process.

The rule finalizes disclosure requirements for the qualifying payment amount and select provisions for the related independent dispute resolution process.

The proposed rule expands the definition of discrimination "on the basis of sex" and explicitly includes telehealth services in nondiscrimination policies.